Diabetes Research Archives - BCDiabetes

On February 1, 2019, the prestigious medical journal the Lancet published a meta-analysis examining potential benefits the statin and class of medication. The article confirmed and extended the powerful evidence for benefit for the use of statins in people with a previous history of heart disease, stroke and for those with diabetes.  It showed that […]

BCDiabetes Medical Director, Dr. Tom Elliott, will be on CKNW radio! Dr. Tom Elliott will speak on John Daly’s radio show Back on the Beat this Saturday, 11:00 am about the benefits of CGM/Sensors, insulin pumps, and GLP-1 agonists. Dr. Tom Elliott will also speak about the new “Trial to Assess Chelation Therapy”. BCDiabetes is […]

  Yesterday, (2017-02-23) a study of diabetic mice was published in the journal “Cell” showing that a special “fasting mimicking diet” (FMD) for 4 days every month caused regeneration of pancreatic insulin-secreting beta cells.  As such, in mice at least, this diet has the potential to reverse both Type 1 and Type 2 diabetes. No […]

The search for a pill formulation of insulin has been long-standing.  Yesterday Novo Nordisk, the world’s biggest insulin manufacturer abandoned its efforts to make an oral form of insulin.  The obstacle was not technological it was price pressure. The pharmaceutical industry has figured out how to protect insulin from digestive juices in the stomach – […]

Yesterday the US Food and Drug Administration approved two new medications – both are shots & each is a combination of two different classes of medication in one shot: a basal long-acting insulin and a GLP-1 receptor agonist. The Novo Nordisk product combines Tresiba, an insulin not yet available in Canada and Victoza while the Sanofi product […]

The US Food and Drug Administration (FDA) approved the first closed-loop insulin-pump sensor system for the diabetes market.  The MiniMed 670G hybrid closed looped system, often referred to as an “artificial pancreas,” is intended to adjust insulin levels with little or no input from the user. It works by measuring glucose levels every five minutes and automatically […]

New study questions Type 2 diabetes treatment “No evidence glucose-lowering drugs help ward off long-term complications, researchers say.” This is a massive statement so we sought our medical director, Dr. Tom Elliott, for insight.   The CBC recently reported on a publication by Dr. Victor Montori, of the Mayo Clinic in Circulation: Cardiovascular Quality and Outcomes arguing a […]

Via Reuters, electronic cigarettes may have helped about 18,000 people in England to give up smoking last year and there is no evidence of any serious side effects associated with their use for up to two years, according to studies published on Tuesday. “For cigarette smokers smoking cessation remains the biggest and most powerful positive health […]

BCDiabetes Medical Director, Dr. Tom Elliott, recently met with Shafin Tejani, Angel Investor of the Year at the 2015 Canadian Startup Awards, to discuss a diabetes-related innovation. While the notion of money and investment in healthcare is nothing new, that diabetes is seen as a cause in addition to a market by people such as […]

A recent article shows that superior performance can be achieved by professional cyclists using ketones as preferred fuel rather than traditional carbohydrate or fat. This information comes hard on the heels of exciting new evidence for the benefits of the sglt2 inhibitor class of drugs in Type 2 diabetes. It may well be that they these […]